Mathias Flume | Head of Drug Department
Kassenarztliche Vereinigung Westfalen-Lippe

Mathias Flume, Head of Drug Department, Kassenarztliche Vereinigung Westfalen-Lippe

  • Management and development of the Business Unit responsible for all prescriptions of approx. 11000 doctors, contracting with sick funds etc.
  • Special interest in the assessment of innovative drugs and their implementation in the regional prescription management
  • Generation and analysis of real world data


Biosimilars Day 1 - Tuesday 31st October 2017 @ 09:50

International stakeholders panel discussion: What does it take to get biosimilars moving in a country?

  • Consisting of industry panellists, physicians, pharmacists, patient advocacy groups, payers, regulators and health authorities, the 360° Perspective Panel allows the whole industry to come together to discuss and debate the sector’s most pertinent topics of the day.
  • With no guarantee that physicians will prescribe biosimilars interchangeably with reference products, what more does the industry need to do to encourage biosimilar uptake within healthcare?
  • What can we learn from gainsharing practices? Carrot & stick models, which works better?
  • How influential are payers in the speed in which biosimilars are taken up in healthcare systems?
  • How does the industry envisage overcoming the challenge that patient communities are generally unaware of this new, yet important, category of medicines?

back to speakers